PetCaseFinder

Peer-reviewed veterinary case report

Effects of two IV fluids on blood clotting in dogs with internal

By Iannucci, Claudia et al.·Published in Journal of veterinary emergency and critical care (San Antonio, Tex. : 2001)·2021·Department of Clinical Veterinary Medicine·View original on PubMed

PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →

Original publication title: A prospective randomized open-label trial on the comparative effects of 6% hydroxyethyl starch 130/0.4 versus polyionic isotonic crystalloids on coagulation parameters in dogs with spontaneous hemoperitoneum.

Species:
dog

Plain-English summary

A group of 42 dogs with spontaneous hemoperitoneum (a condition where there is bleeding in the abdominal cavity) were treated to see how two different fluids affected their blood clotting. Half of the dogs received a hydroxyethyl starch solution, while the other half received a polyionic crystalloid solution. The results showed that the dogs given the hydroxyethyl starch had longer clot formation times and weaker clots compared to those given the crystalloid solution. While the hydroxyethyl starch did not cause excessive bleeding, it appeared to negatively affect blood clotting compared to the other treatment.

People also search for: dog spontaneous hemoperitoneum treatment · hydroxyethyl starch effects in dogs · dog bleeding in abdomen treatment

Abstract

OBJECTIVE: To evaluate the effects of 6% hydroxyethyl starch 130/0.4 (HES) and a polyionic isotonic crystalloid (CRYS) on standard coagulation tests and rotational thromboelastometry (ROTEM) in dogs with spontaneous hemoperitoneum (SHP). DESIGN: Prospective randomized open-label clinical study. SETTING: University teaching hospital. ANIMALS: Forty-two client-owned dogs presented with SHP. INTERVENTIONS: Dogs diagnosed with SHP and hypovolemic shock were randomly allocated to receive HES (10 mL/kg, n = 22) or CRYS (30 mL/kg, n = 20) intravenously over 20 minutes for hemodynamic stabilization. MEASUREMENTS AND MAIN RESULTS: Parameters measured before (T) and after (T) treatment were HCT, platelet counts, prothrombin time, activated partial thromboplastin time, fibrinogen concentrations, and extrinsic activated (EXTEM), intrinsic activated (INTEM), and extrinsic activated with platelet inhibition ROTEM assays. Data were analyzed as absolute values and as the percentage change from Tto T. No significant differences between groups were detected in any variable at T, and for HCT, platelet counts, prothrombin time, activated thromboplastin time, and fibrinogen concentrations at T. Clot formation time in EXTEM was significantly prolonged (P = 0.037), and maximum clot firmness was significantly decreased (P = 0.038) in the HES group compared to the CRYS group at T. The percentage change in EXTEM clotting time (P = 0.012) and INTEM clot formation time (P = 0.031) was greater after HES than CRYS. Lysis indices remained at 100% for all ROTEM assays in both groups. CONCLUSION: Compared to a 3-fold volume of CRYS, administration of HES was associated with impairment in ROTEM parameters in dogs with SHP, but no evidence of hyperfibrinolysis was detected.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/33108052/